Reply to ‘Correcting the ASCO position on phase I clinical trials in cancer’
Crossref DOI link: https://doi.org/10.1038/s41571-019-0312-3
Published Online: 2019-12-19
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kimmelman, Jonathan http://orcid.org/0000-0003-1614-6779
Text and Data Mining valid from 2019-12-19
Version of Record valid from 2019-12-19
Article History
First Online: 19 December 2019